Providing a high-quality, reliable and cost-effective pathology service is the priority for today’s NHS. Beckman Coulter’s Ibti Rashid explains why the company’s laboratory automation customers excel in these areas.
Beckman Coulter is celebrating the five-year anniversary of its acquisition by Danaher Corporation, one of the world’s most successful global science and technology innovators, advancing patient health by delivering diagnostic confidence.
Danaher’s consistently high performance over many years is built on a set of strategic and tactical business tools called Danaher Business Systems (DBS). This inspires a strong culture of continuous improvement, with quality and reliability always at the heart of everything we set out to achieve. This starts with on-going continuous improvement projects for current solutions, and continues throughout research and development for our innovation pipeline.
We ensure maximum quality and reliability in the products we manufacture, so laboratories consistently produce quality results, on time. Combined with our drive for automating as much specialist testing as possible into routine blood science laboratories, we are able to provide customers with the peace of mind they need to focus on their future planning.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
